Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Replimune Group Inc’s current trading price is -55.29% away from its 52-week high, while its distance from the 52-week low is 183.58%. The stock’s price range during this period has varied between $2.68 and $17.00. The company, active in the Healthcare sector, saw a trading volume of around 9.71 million for the day, considerably higher average daily volume of 7.84 million observed over the last three months.
Replimune Group Inc (REPL) currently has a stock price of $7.6. The stock saw a sharp increase in the last trading session, hitting a high of $9.0 after opening at $7.6. The lowest recorded price for the day was $2.0 before it closed at $7.03.
Replimune Group Inc had a pretty Dodgy run when it comes to the market performance.
How Financial Performance Impacts Market Capitalization
Replimune Group Inc (REPL) has experienced a quarterly decline of -21.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 591.33M and boasts a workforce of 479 employees.
Decoding Analysts’ Ratings for Replimune Group Inc
As of right now, 2 analysts are rating Replimune Group Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 6 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.02, with a change in price of -3.54. Similarly, Replimune Group Inc recorded 5,353,565 in trading volume during the last 100 days, posting a change of -31.78%.
How REPL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for REPL stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.17.
REPL Stock Stochastic Average
As of today, the raw stochastic average of Replimune Group Inc over the last 50 days is at 46.59%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 46.59%. Further, the company’s Stochastic %K and %D values for the last 20 days were 44.63% and 32.47%, respectively.
REPL Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -24.75%.However, over the last six months, we can see a stronger performance of -44.20%. Over the last 30 days, the price of REPL has leaped by -20.42%. And in the last five days, it has surged by 141.27%.
